CytomX Therapeutics, Inc. CTMX Balance Sheet

Cytomx therapeutics, inc. (CTMX)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Dec'14
Assets
Current assets:
Cash and cash equivalents
143,286	188,425	164,646	149,392	190,407	247,577	259,753	132,908	142,155	177,548	284,225	272,860	85,662	104,645	59,758	62,379	67,897	59,822	36,191	64,396
Short-term investments
104,636	107,720	161,067	199,750	206,189	188,550	-	-	-	196,562	-	-	-	-	-	-	-	-	-	-
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100	100
Short-term investments
-	-	-	-	-	-	204,809	202,238	219,321	-	47,050	63,056	76,861	77,293	118,707	133,418	112,739	126,889	77,495	0
Accounts receivable
130,010	13	7	10,004	44	97	56	25,137	81	10,139	40,183	158	213	2,159	240	285	316	372	406	1,875
Income tax receivable
13,061	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Related party accounts receivable
-	-	-	-	-	-	-	-	-	-	68	27	55	154	207	113	158	372	-	-
Prepaid expenses and other current assets
9,073	7,177	9,058	7,531	8,437	9,251	7,890	6,388	5,474	4,352	4,848	4,579	4,118	3,896	4,401	3,411	3,438	2,299	878	482
Total current assets
400,066	303,335	334,778	366,677	405,077	445,475	472,508	366,671	367,031	388,601	376,374	340,680	166,909	188,147	183,313	199,606	184,548	189,754	115,070	66,853
Long-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,025	-	-	-	-	-
Property and equipment, net
7,393	7,372	7,107	7,238	7,369	6,934	5,482	5,499	4,622	4,218	4,087	4,319	4,604	4,392	3,701	3,370	3,479	3,481	3,667	3,018
Intangible assets, net
1,276	1,312	1,349	1,385	1,422	1,458	1,495	1,531	1,568	1,604	1,641	1,750	1,750	1,750	1,750	1,750	1,750	1,750	1,750	1,750
Goodwill
949	949	949	949	949	949	949	949	949	949	949	949	949	949	949	949	949	949	949	949
Restricted cash
917	917	917	917	917	917	917	917	917	917	917	917	917	917	917	917	917	917	-	-
Operating lease right-of-use asset
24,682	25,382	26,069	26,743	27,404	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
1,379	2,015	1,375	1,375	1,375	1,375	1,375	1,375	1,375	1,355	3,071	3,240	2,753	2,973	226	268	309	364	3,343	492
Total assets
436,662	341,282	372,544	405,284	444,513	457,108	482,726	376,942	376,462	397,644	387,039	351,855	177,882	199,128	192,881	206,860	191,952	197,215	124,779	73,062
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
3,782	4,158	4,550	4,520	9,511	5,132	6,871	4,240	5,349	4,205	2,869	6,364	3,700	6,596	517	1,426	4,958	4,697	2,700	1,919
Accrued liabilities
28,353	30,051	20,496	22,469	22,567	26,724	21,416	24,768	16,335	16,382	11,444	7,499	6,336	8,824	9,041	7,313	4,738	4,912	5,143	1,695
Income tax payable
-	-	-	-	13,374	13,339	4,990	2,692	1,035	1	-	-	-	-	-	-	-	-	-	-
Deferred revenue, current portion
73,866	51,381	51,080	51,684	50,765	52,713	52,997	51,512	46,988	40,559	56,928	46,772	27,090	20,347	14,124	13,485	7,307	6,130	6,130	6,130
Long-term debt, current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,419
Total current liabilities
106,001	85,590	76,126	78,673	96,217	97,908	86,274	83,212	69,707	61,147	71,241	60,635	37,126	35,767	23,682	22,224	17,003	15,739	13,973	11,163
Deferred revenue, net of current portion
236,789	178,858	187,725	197,826	197,754	225,267	236,365	250,316	255,053	264,704	267,996	237,053	65,477	83,803	79,110	82,783	61,725	54,703	56,236	60,833
Operating lease liabilities - long term
24,105	24,871	25,621	26,321	27,008	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long-term debt, net of current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,568
Convertible preferred stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	788	186
Convertible preferred stock liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	395
Deferred tax liability
-	-	-	-	-	-	-	-	-	-	520	539	514	513	513	513	510	507	507	499
Other long-term liabilities
-	850	963	963	963	3,050	2,426	2,281	2,055	1,897	1,803	1,391	978	566	154	153	-	198	244	249
Total liabilities
366,895	290,169	290,435	303,783	321,942	326,225	325,065	335,809	326,815	327,748	341,560	299,618	104,095	120,649	103,459	105,673	79,238	71,147	71,748	74,893
Commitments and contingencies (Note 11)
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0
Redeemable convertible preferred stock, $0.00001 par value 0 and 21,759,654 shares authorized at December 31, 2015 and 2014, respectively; 0 and 18,458,289 shares issued and outstanding at December 31, 2015 and 2014
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	76,710
Stockholders' equity:
Convertible preferred stock, $0.00001 par value; 10,000,000 shares authorized; and no shares issued and outstanding at March 31, 2020 and December 31, 2019.
-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	0
Common stock, $0.00001 par value; 75,000,000 shares authorized; 45,918,616 and 45,523,088 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Stockholders notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	78	78	78	404
Additional paid-in capital
474,455	468,285	463,773	459,367	451,613	445,956	440,616	300,627	295,744	289,454	265,625	262,185	258,509	254,871	251,748	248,777	246,256	243,687	-	-
Accumulated other comprehensive income
336	57	110	209	73	-93	-208	-178	-228	-94	-61	-110	-100	-27	6	80	30	-76	8	-
Accumulated deficit
-405,025	-417,230	-381,775	-358,076	-329,116	-314,981	-282,748	-259,317	-245,870	-219,465	-220,086	-209,839	-184,623	-176,366	-162,333	-147,671	-133,495	-117,466	-105,979	-78,138
Total stockholders' equity
69,767	51,113	82,109	101,501	122,571	130,883	157,661	41,133	49,647	69,896	45,479	52,237	73,787	78,479	89,422	101,187	112,714	126,068	-106,048	-78,541
Total liabilities and stockholders' equity
436,662	341,282	372,544	405,284	444,513	457,108	482,726	376,942	376,462	397,644	387,039	351,855	177,882	199,128	192,881	206,860	191,952	197,215	124,779	73,062